Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers.
Publication
, Journal Article
Armstrong, AJ
Published in: Urol Oncol
November 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Urol Oncol
DOI
EISSN
1873-2496
Publication Date
November 2016
Volume
34
Issue
11
Start / End Page
488 / 489
Location
United States
Related Subject Headings
- Urology & Nephrology
- Urogenital Neoplasms
- Humans
- Biomarkers, Tumor
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J. (2016). Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers. Urol Oncol, 34(11), 488–489. https://doi.org/10.1016/j.urolonc.2016.09.009
Armstrong, Andrew J. “Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers.” Urol Oncol 34, no. 11 (November 2016): 488–89. https://doi.org/10.1016/j.urolonc.2016.09.009.
Armstrong AJ. Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers. Urol Oncol. 2016 Nov;34(11):488–9.
Armstrong, Andrew J. “Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers.” Urol Oncol, vol. 34, no. 11, Nov. 2016, pp. 488–89. Pubmed, doi:10.1016/j.urolonc.2016.09.009.
Armstrong AJ. Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers. Urol Oncol. 2016 Nov;34(11):488–489.
Published In
Urol Oncol
DOI
EISSN
1873-2496
Publication Date
November 2016
Volume
34
Issue
11
Start / End Page
488 / 489
Location
United States
Related Subject Headings
- Urology & Nephrology
- Urogenital Neoplasms
- Humans
- Biomarkers, Tumor
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis